Effects of flavonoids from Potamogeton crispus L. On proliferation, migration, and invasion of human ovarian cancer cells

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Du, Yuanda ^a   Feng, Jinhong ^b   Wang, Renqing ^a   Zhang, Haijie ^a   Liu, Jian ^a  

^a SHANDONG UNIVERSITY   (China)

^b QILU UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONE 6 C BETA DEXTRO GLUCOPYRANOSIDE; FLAVONOID; GELATINASE A; GELATINASE B; LIPOCORTIN 5; LUTEOLIN 3' O BETA DEXTRO GLUCOPYRANOSIDE; UNCLASSIFIED DRUG; LUTEOLIN; MESSENGER RNA;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE ARREST; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; METASTASIS INHIBITION; OVARY CANCER; POTAMOGETON; POTAMOGETON CRISPUS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CYCLE; CELL MOTION; CHEMISTRY; DRUG EFFECTS; METABOLISM; OVARY TUMOR; PATHOLOGY; POTAMOGETONACEAE; TUMOR CELL LINE;

POTAMOGETON; POTAMOGETON CRISPUS;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLAVONOIDS; HUMANS; LUTEOLIN; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OVARIAN NEOPLASMS; POTAMOGETONACEAE; RNA, MESSENGER;

EID: 84939140373     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130685     Document Type: Article

References (46)

1. Jian YX, Li B, Wang JB, Chen JK. Control of turion germination in Potamogeton crispus. Aquat Bot. 2003;75:59-69.
2. Ye M, Ma JZ, Xiong J, Liu ST, Wang D, Yuan CJ, et al. Chemical constituents from the submerged plant Potamogeton crispus and their effects on NAD (P) H: quinone oxidoreductase 1. Chinese Chemical Letters. 2012;23:1157-1160.
3. Waridel P, Wolfender JL, Lachavanne JB, Hostettmann K. Identification of the polar constituents of Potamogeton species by HPLC-UV with post-column derivatization, HPLC-MSn and HPLC-NMR, and isolation of a new ent-labdane diglycoside. Phytochemistry. 2004;65:2401-2410. PMID: 15381014
4. Waridel P, Wolfender JL, Lachavanne JB, Hostettmann K. ent-Labdane glycosides from the aquatic plant Potamogeton lucens and analytical evaluation of the lipophilic extract constituents of various Potamogeton species. Phytochemistry. 2004;65:945-954. PMID: 15081300
5. Ren D, Zhang S. Separation and identification of the yellow carotenoids in Potamogeton crispus L. Food Chemistry. 2008;106:410-414.
6. Ren D, Peng G, Huang H, Wang H, Zhang S. Effect of rhodoxanthin from Potamogeton crispus L. on cell apoptosis in Hela cells. Toxicol in Vitro. 2006 20:1411-1418. PMID: 16919415
7. Du YD, Wang RQ, Feng JH, Zhang HJ, Liu J. Screening anti-tumor constituents from Potamogeton crispus for potential utilisation of constructed wetland plant resources. Biol Environ. 2014;114:79-87.
8. Harborne JB, Wliiiams CA. Advances in flavonoid research since 1992. Phytochemistry. 2000;55:481-504. PMID: 11130659
9. Verma AK, Pratap R. Chemistry of biologically important flavones. Tetrahedron. 2012;68:8523-8538. doi: 10.1039/c2cc34188c PMID: 22801641
10. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Therapeut. 2002;96:67-202. PMID: 12453566
11. Delmas D, Xiao JB. Natural polyphenols properties: Chemopreventive and chemosensitizing activities. Anti-Cancer Agents Med Chem. 2012;12:835. PMID: 22583400
12. Andrae-Marobela K, Ghislain FW, Okatch H, Majinda R. Polyphenols: A diverse class of multi-target anti-HIV-1 agents. Curr Drug Metab. 2013;7:392-413.
13. Deng GF, Xu XR, Zhang Y, Li D, Gan RY, Li HB. Phenolic compounds and bioactivities of pigmented rice. Crit Rev Food Sci Nutr. 2013;53:296-306. doi: 10.1080/10408398.2010.529624 PMID: 23216001
14. Xiao JB, Tundis R. Natural products for Alzheimer's disease therapy: basic and application. Pharm Pharmacol. 2013;65:1679-80. doi: 10.1111/jphp. 12186 PMID: 24236979
15. Kobayashi T, Nakata T, Kuzumaki T. Effect of flavonoids on cell cycle progression in prostate cncer cells. Cancer Lett. 2002;176:12-23.
16. Khan MK, Zill EH, Dangles O. A comprehensive review on flavanones, the major citrus polyphenols. J Food Compos Anal. 2014;33:85-104.
17. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895-904. PMID: 16892035
18. Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS Journal. 2011;278:16-27. doi: 10.1111/j.1742-4658.2010. 07919.x PMID: 21087457
19. Coticchia CM, Curatolo AS, Zurakowski D, Yang J, Daniels KE, Matulonis UA, et al. Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. Gynecol Oncol. 2011;123:295-300. doi: 10.1016/j.ygyno. 2011.07.034 PMID: 21889192
20. Wang L, Ling Y, Chen Y, Li CL, Feng F, You QD, et al. Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 2010;297:42-48. doi: 10.1016/j.canlet.2010.04.022 PMID: 20580866
21. Park SH, Kim JH, Lee DH, Kang JW, Song HH, Oh SR, et al. Luteolin 8-C-beta-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-kappaB signaling in MCF-7 breast cancer cells. Biochimie. 2013;95:2082-2090. doi: 10.1016/j.biochi.2013.07.021 PMID: 23933110
22. Chen K, Zhang S, Ji Y, Li J, An P, Ren H, et al. Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway. PLoS ONE. 2013;8:e72927. doi: 10.1371/journal.pone.0072927 PMID: 24039823
23. Markham KR, Ternai B, Stanley R, Geiger H, Mabry TJ. Carbon-13 NMR studies of flavonoids-III: Naturally occurring flavonoid glycosides and their acylated derivatives. Tetrahedron. 1978;34:1389-1397.
24. Nawwar MAM, Hussein SAM, Merfort I. Leaf phenolics of Punica granatum. Phytochemistry. 1994;37:1175-1177.
25. Krafczyk N, Glomb MA. Characterization of Phenolic Compounds in Rooibos Tea. J. Agric. Food Chem. 2008;56:3368-3376. doi: 10.1021/jf703701n PMID: 18399640
26. Li X, Yang G, Li X, Zhang Y, Yang J, Chang J, et al. Traditional Chinese Medicine in Cancer Care: A Review of Controlled Clinical Studies Published in Chinese. PLoS ONE. 2013;8:e60338. doi: 10. 1371/journal.pone.0060338 PMID: 23560092
27. Xiao J, Muzashvili TS, Georgiev MI. Advances in the biotechnological glycosylation of valuable flavonoids. Biotechnol Adv. 2014;32:1145-1156. doi: 10.1016/j.biotechadv. 2014.04.006 PMID: 24780153
28. Tsai YD, Chen HJ, Hsu HF, Lu K, Liang CL, Liliang PC, et al. Luteolin inhibits proliferation of human glioblastoma cells via induction of cell cycle arrest and apoptosis. Journal of the Taiwan Institute of Chemical Engineers. 2013;44:837-845.
29. Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, Gaben AM, et al. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol. 2011;651:18-25. doi: 10.1016/j.ejphar.2010.10.063 PMID: 21074525
30. Walle T, Browning AM, Steed LL, Reed SG, Walle UK. Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr. 2005;135:48-52. PMID: 15623831
31. Xiao J, Chen T, Cao H. Flavonoid glycosylation and biological benefits. Biotechnol Adv. doi: 10.1016/j. biotechadv. 2014.05.004
32. Choi AY, Choi JH, Yoon H, Hwang KY, Noh MH, Choe W, et al. Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells. Eur J Pharmacol. 2011;668:115-126. doi: 10.1016/j.ejphar.2011.06.047 PMID: 21762691
33. Cai X, Ye T, Liu C, Lu W, Lu M, Zhang J, et al. Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. Toxicol In Vitro. 2011;25:1385-1391. doi: 10.1016/j.tiv. 2011. 05.009 PMID: 21601631
34. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991;64:327-336. PMID: 1703045
35. Stetler-Stevenson WG. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am. 2001;10:383-392. PMID: 11382593
36. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25:9-34. PMID: 16680569
37. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003;253:269-285. PMID: 14619979
38. Delassus GS, Cho H, Park J, Eliceiri GL. New pathway links from cancerprogression determinants to gene expression of matrix metalloproteinases inbreast cancer cells. J Cell Physiol. 2008;217, 739-744. doi: 10.1002/jcp. 21548 PMID: 18651563
39. Kim JH, Kim MS, Bak Y, Chung IM, Yoon DY. The cadin-2-en-1beta-ol-1beta-D-glucuronopyranoside suppresses TPA-mediated matrix metalloproteinase-9 expression through the ERK signaling pathway in MCF-7human breast adenocarcinoma cells. J Pharmacol Sci. 2012;118:198-205. PMID: 22293298
40. Hsieh CY, Tsai PC, Tseng CH, Chen YL, Chang LS, Lin SR, et al. Inhibition of EGF/EGFR activation with naphtho[1, 2-b]furan-4, 5-dione blocks migration and invasion of MDA-MB-231 cells. Toxicol In Vitro. 2013;27:1-10. doi: 10.1016/j.tiv. 2012.10.001 PMID: 23064031
41. Hsieh CY, Tsai PC, Chu CL, Chang FR, Chang LS, Wu YC, et al. Brazilein suppresses migration and invasion of MDA-MB-231 breast cancer cells. Chem Biol Interact. 2013;204:105-115. doi: 10.1016/j. cbi.2013.05.005 PMID: 23707804
42. Yamazaki S, Miyoshi N, Kawabata K, Yasuda M, Shimoi K. Quercetin-3-O-glucuronide inhibits noradrenalinepromoted invasion of MDA-MB-231 human breast cancer cells by blocking beta (2)-adrenergic signaling. Arch Biochem Biophys. 2014;557:18-27. doi: 10.1016/j.abb.2014.05.030 PMID: 24929186
43. Yodkeeree S, Ampasavate C, Sung B, Aggarwal BB, Limtrakul P. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur J Pharmacol. 2010;627:8-15. doi: 10.1016/j.ejphar.2009.09.052 PMID: 19818349
44. Chen YJ, Cheng YJ, Hung AC, Wu YC, Hou MF, Tyan YC, et al. The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration/invasion and angiogenesis via MAPK14 signaling. Gynecol Oncol. 2013;131:734-743. doi: 10.1016/j.ygyno. 2013.10.012 PMID: 24145114
45. Lee EJ, Oh SY, Sung MK. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells. Food Chem Toxicol. 2012;50:4136-4143. doi: 10.1016/j.fct.2012.08.025 PMID: 22926442
46. Cordell GA, Colvard MD. Natural products and traditional medicine: turning on a paradigm. J Nat Prod. 2012;75:514-525. doi: 10.1021/np200803m PMID: 22233451